Autopsy report · NCT06414824
The isCGM Use and Hypoglycemic Episodes and Fear of Hypoglycemia in Newly Diagnosed Type 1 Diabetes
Cause of deathSlow enrollment
“The study ended early due to CGM reimbursement policy changes, after that most patients eligible for the study could have isCGM reimbursed.”
Life of this trial
- Registered 2 years after it had already started.
- Ran for about 2 years 1 month before it stopped.
- 28 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Jagiellonian University
- Sponsor type
- University, hospital or other
- Conditions
- Diabetes Mellitus, Type 1
- Interventions
- Intermittently Scanned Continuous Glucose Monitoring; Standard Blood Glucose Monitoring
- Participants
- 28
- Sites
- 4
- Countries
- Poland
Trials that died the same way
- A Study of Retreatment With Brentuximab Vedotin in Subjects With Classic Hodgkin Lymphoma or CD30-expressing Peripheral T Cell Lymphoma
“Study stopped early due to low patient accrual.” - A Reminder App to Reduce Radiation Dermatitis Rates in Patients with Head-and-Neck Cancer
“After the planned interim analysis, the study was terminated. The start of the trial was delayed due to data protection issues and the Covid-19 pandemic. Moreover, accrual was slower than expected. Finally, funding has expired.” - Clinical Efficacy of Intense Pulsed Light(IPL) Procedure in Dry Eye Patient
“Due to the covid 19, patient recruiment is not going smoothly, so the study was canceled.” - Safety and Tolerability of PRO-143 Ophthalmic Solution in Healthy Volunteers.
“the clinical study was canceled by the sponsor due to logistics and programming” - PFC Sigma Fixed and Mobile Knee Study
“The study was terminated at the point the primary endpoint and early milestones were reached and because long term outcomes were available from other sources”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.